Orthopedic Surgery Adhesion Barrier refers to bio‑engineered membranes or gels applied during joint and spinal procedures to prevent post‑operative fibrous tissue formation and improve functional recovery. The Orthopedic Surgery Adhesion Barrier market size is a critical indicator of healthcare investment in surgical outcomes, and the growth outlook, market forecast, and industry expansion are closely tracked by device manufacturers and hospital procurement teams.
In 2025, the global market was estimated at approximately USD 1.3 billion, driven by an aging population, rising joint‑replacement volumes, and heightened clinical emphasis on minimizing adhesions. The market is projected to expand at a compound annual growth rate (CAGR) of around 6 % from 2026 to 2033. Key forces shaping the landscape include rapid technological advances in bioresorbable polymers, evolving regulatory pathways that streamline product approvals, and intensifying competitive dynamics as incumbents launch next‑generation barrier solutions while new entrants leverage niche innovations.